<?xml version="1.0" encoding="UTF-8"?><brca:tcga_bcr xmlns:brca="http://tcga.nci/bcr/xml/clinical/brca" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.3" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.3" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.3" xmlns:shared="http://tcga.nci/bcr/xml/clinical/shared/2.3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" schemaVersion="2.3" xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/brca TCGA_BCR.BRCA_Clinical.xsd">
    <admin:admin>
        <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
        <admin:batch_number xsd_ver="1.17">47.3.0</admin:batch_number>
        <admin:disease_code xsd_ver="1.17">BRCA</admin:disease_code>
        <admin:days_to_dcc_upload cde="" precision="day" xsd_ver="1.16">925</admin:days_to_dcc_upload>
    </admin:admin>
    <brca:patient>
        <shared:tumor_tissue_site cde="2735776" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="1.8">BREAST</shared:tumor_tissue_site>
        <shared:prior_diagnosis cde="61396" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">NO</shared:prior_diagnosis>
        <shared:gender cde="2200604" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="1.8">FEMALE</shared:gender>
        <shared:vital_status cde="2939553" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="1.8">LIVING</shared:vital_status>
        <shared:days_to_birth cde="" owner="TSS" precision="day" procurement_status="Completed" tier="1" xsd_ver="1.16">-22114</shared:days_to_birth>
        <shared:days_to_last_known_alive cde="" owner="TSS" precision="day" procurement_status="Completed" tier="1" xsd_ver="1.16">643</shared:days_to_last_known_alive>
        <shared:days_to_death cde="" owner="TSS" procurement_status="Not Applicable" tier="1" xsd_ver="1.16"/>
        <shared:days_to_last_followup cde="" owner="TSS" precision="day" procurement_status="Completed" tier="1" xsd_ver="1.16">643</shared:days_to_last_followup>
        <shared:race cde="2192199" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="1.8">BLACK OR AFRICAN AMERICAN</shared:race>
        <shared:bcr_patient_barcode cde="2673794" owner="TSS" procurement_status="Completed" xsd_ver="1.8">TCGA-A2-A0D0</shared:bcr_patient_barcode>
        <shared:bcr_patient_uuid cde="" owner="TSS" procurement_status="Completed" xsd_ver="2.3"/>
        <shared:pretreatment_history cde="64176" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="1.8">NO</shared:pretreatment_history>
        <shared:radiation_therapy cde="2005312" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="1.9"/>
        <shared:informed_consent_verified cde="2714689" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="1.10">YES</shared:informed_consent_verified>
        <shared:days_to_initial_pathologic_diagnosis cde="" owner="TSS" precision="day" procurement_status="Completed" tier="1" xsd_ver="1.16">0</shared:days_to_initial_pathologic_diagnosis>
        <shared:age_at_initial_pathologic_diagnosis cde="" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="1.16">60</shared:age_at_initial_pathologic_diagnosis>
        <shared:year_of_initial_pathologic_diagnosis cde="2896960" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="1.12">2008</shared:year_of_initial_pathologic_diagnosis>
        <shared:days_to_new_tumor_event_after_initial_treatment cde="" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="1.16"/>
        <shared:ethnicity cde="2192217" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="1.9">NOT HISPANIC OR LATINO</shared:ethnicity>
        <shared:additional_radiation_therapy cde="3008761" owner="TSS" procurement_status="Not Available" tier="2" xsd_ver="2.2"/>
        <shared:additional_pharmaceutical_therapy cde="2650646" owner="TSS" procurement_status="Not Available" tier="2" xsd_ver="2.2"/>
        <shared:additional_surgery_locoregional_procedure cde="3008755" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <shared:days_to_additional_surgery_locoregional_procedure cde="" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="1.16"/>
        <shared:additional_surgery_metastatic_procedure cde="3008757" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <shared:days_to_additional_surgery_metastatic_procedure cde="" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="1.16"/>
        <shared:person_neoplasm_cancer_status cde="2759550" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="1.9">TUMOR FREE</shared:person_neoplasm_cancer_status>
        <brca:lymph_node_examined_count cde="3" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">8</brca:lymph_node_examined_count>
        <brca:er_detection_method_text cde="69" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:pgr_detection_method_text cde="785" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:breast_tumor_pathologic_t_stage cde="2370" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">T2</brca:breast_tumor_pathologic_t_stage>
        <brca:breast_tumor_pathologic_n_stage cde="2372" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">pN0(i-)</brca:breast_tumor_pathologic_n_stage>
        <brca:anatomic_site_location_descriptors>
            <brca:anatomic_site_location_descriptor cde="2008006" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">Left Upper Outer Quadrant</brca:anatomic_site_location_descriptor>
        </brca:anatomic_site_location_descriptors>
        <brca:her2_neu_chromosone_17_signal_ratio_value cde="2497552" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">1.17</brca:her2_neu_chromosone_17_signal_ratio_value>
        <brca:axillary_lymph_node_stage_method_type cde="2516112" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">Axillary lymph node dissection alone</brca:axillary_lymph_node_stage_method_type>
        <brca:axillary_lymph_node_stage_other_method_descriptive_text cde="3124496" owner="TSS" procurement_status="Not Applicable" tier="1" xsd_ver="2.2" xsi:nil="true"/>
        <brca:primary_other_site_of_disease_name cde="2584114" owner="TSS" procurement_status="Not Applicable" tier="1" xsd_ver="2.2" xsi:nil="true"/>
        <brca:breast_carcinoma_surgical_procedure_name cde="2739580" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:breast_neoplasm_other_surgical_procedure_descriptive_text cde="3124493" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:breast_carcinoma_first_surgical_procedure_name cde="2739580" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">Simple Mastectomy</brca:breast_carcinoma_first_surgical_procedure_name>
        <brca:surgical_procedure_purpose_other_text cde="2467630" owner="TSS" procurement_status="Not Applicable" tier="1" xsd_ver="2.2" xsi:nil="true"/>
        <brca:breast_cancer_optical_measurement_histologic_type cde="2549638" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">Infiltrating Ductal</brca:breast_cancer_optical_measurement_histologic_type>
        <brca:tumor_other_histologic_subtype_descriptive_text cde="3124492" owner="TSS" procurement_status="Not Applicable" tier="1" xsd_ver="2.2" xsi:nil="true"/>
        <brca:person_menopause_status cde="2957270" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">Post (prior bilateral ovariectomy OR &gt;12 mo since LMP with no prior hysterectomy)</brca:person_menopause_status>
        <brca:breast_carcinoma_progesterone_receptor_status cde="2957357" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">Negative</brca:breast_carcinoma_progesterone_receptor_status>
        <brca:cytokeratin_immunohistochemistry_staining_method_micrometastasis_indicator cde="3086152" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">NO</brca:cytokeratin_immunohistochemistry_staining_method_micrometastasis_indicator>
        <brca:immunohistochemistry_positive_cell_score cde="2230166" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">0</brca:immunohistochemistry_positive_cell_score>
        <brca:her2_immunohistochemistry_level_result cde="2178402" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">0</brca:her2_immunohistochemistry_level_result>
        <brca:breast_cancer_surgery_margin_status cde="2241252" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:disease_surgical_margin_status cde="3114007" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">Negative</brca:disease_surgical_margin_status>
        <brca:first_pathologic_diagnosis_biospecimen_acquisition_method_type cde="2757941" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.3">Core needle biopsy</brca:first_pathologic_diagnosis_biospecimen_acquisition_method_type>
        <brca:first_pathologic_diagnosis_biospecimen_acquisition_other_method_text cde="2757948" owner="TSS" procurement_status="Not Applicable" tier="1" xsd_ver="2.2" xsi:nil="true"/>
        <brca:adjuvant_postop_targeted_therapy_admin_indicator cde="2785850" owner="TSS" procurement_status="Not Available" tier="2" xsd_ver="2.2"/>
        <brca:lab_procedure_her2_neu_in_situ_hybrid_outcome_type cde="2854089" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">Negative</brca:lab_procedure_her2_neu_in_situ_hybrid_outcome_type>
        <brca:breast_carcinoma_estrogen_receptor_status cde="2957359" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">Negative</brca:breast_carcinoma_estrogen_receptor_status>
        <brca:lab_proc_her2_neu_immunohistochemistry_receptor_status cde="2957563" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">Negative</brca:lab_proc_her2_neu_immunohistochemistry_receptor_status>
        <brca:pos_finding_lymph_node_keratin_immunohistochemistry_staining_method_count cde="3086383" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">0</brca:pos_finding_lymph_node_keratin_immunohistochemistry_staining_method_count>
        <brca:pos_finding_lymph_node_hematoxylin_and_eosin_staining_microscopy_count cde="3086388" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">0</brca:pos_finding_lymph_node_hematoxylin_and_eosin_staining_microscopy_count>
        <brca:pos_finding_progesterone_receptor_other_measurement_scale_text cde="3086857" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:positive_finding_estrogen_receptor_other_measurement_scale_text cde="3086851" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:her2_erbb_pos_finding_cell_percent_category cde="3086980" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:pos_finding_her2_erbb2_other_measurement_scale_text cde="3087479" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:her2_erbb_method_calculation_method_text cde="3087487" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count cde="3087902" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2" xsi:nil="true"/>
        <brca:her2_and_centromere_17_positive_finding_other_measurement_scale_text cde="3087923" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text cde="3087929" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:tissue_prospective_collection_indicator cde="3088492" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.2">NO</brca:tissue_prospective_collection_indicator>
        <brca:tissue_retrospective_collection_indicator cde="3088528" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.2">YES</brca:tissue_retrospective_collection_indicator>
        <brca:fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range cde="3104295" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:first_nonlymph_node_metastasis_anatomic_sites>
            <brca:first_nonlymph_node_metastasis_anatomic_site cde="3124499" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
            <brca:first_recurrent_non_nodal_metastatic_anatomic_site_descriptive_text cde="3124503" owner="TSS" procurement_status="Not Applicable" tier="1" xsd_ver="2.2" xsi:nil="true"/>
        </brca:first_nonlymph_node_metastasis_anatomic_sites>
        <brca:breast_tumor_clinical_m_stage cde="3128320" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">M0</brca:breast_tumor_clinical_m_stage>
        <brca:er_level_cell_percentage_category cde="3128341" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">&lt;10%</brca:er_level_cell_percentage_category>
        <brca:progesterone_receptor_level_cell_percent_category cde="3128342" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">&lt;10%</brca:progesterone_receptor_level_cell_percent_category>
        <brca:metastatic_breast_carcinoma_estrogen_receptor_status cde="3131865" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category cde="3131869" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score cde="3131873" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text cde="3131877" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_estrogen_receptor_detection_method_text cde="3131881" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_progesterone_receptor_status cde="3131884" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status cde="3131997" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category cde="3131891" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score cde="3131988" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text cde="3131992" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_progesterone_receptor_detection_method_text cde="3131993" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category cde="3132322" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result cde="3132444" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text cde="3132448" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text cde="3132452" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type cde="3132455" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range cde="3132887" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count cde="3132899" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2" xsi:nil="true"/>
        <brca:metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value cde="3132903" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2" xsi:nil="true"/>
        <brca:metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text cde="3132907" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text cde="3132910" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2"/>
        <brca:her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number cde="3133734" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2" xsi:nil="true"/>
        <brca:her2_neu_breast_carcinoma_copy_analysis_input_total_number cde="3133738" owner="TSS" procurement_status="Not Available" tier="1" xsd_ver="2.2" xsi:nil="true"/>
        <brca:breast_carcinoma_immunohistochemistry_pos_cell_score cde="3133874" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">0</brca:breast_carcinoma_immunohistochemistry_pos_cell_score>
        <brca:breast_tumor_pathologic_grouping_stage cde="3134022" owner="TSS" procurement_status="Completed" tier="1" xsd_ver="2.2">IIA</brca:breast_tumor_pathologic_grouping_stage>
        <shared:days_to_form_completion cde="" owner="TSS" precision="day" procurement_status="Completed" tier="" xsd_ver="1.16">868</shared:days_to_form_completion>
        <rx:drugs>
            <rx:drug>
                <rx:regimen_number cde="2673845" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.1">1</rx:regimen_number>
                <rx:bcr_drug_barcode owner="TSS" procurement_status="Completed" xsd_ver="1.15">TCGA-A2-A0D0-D1851</rx:bcr_drug_barcode>
                <rx:bcr_drug_uuid cde="" owner="TSS" procurement_status="Completed" xsd_ver="2.3"/>
                <rx:drug_category cde="729" owner="TSS" procurement_status="Not Applicable" tier="2" xsd_ver="1.8"/>
                <rx:total_dose cde="1515" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.1">4920</rx:total_dose>
                <rx:total_dose_units cde="3088785" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.1">mg</rx:total_dose_units>
                <rx:prescribed_dose cde="2184728" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.1">1230</rx:prescribed_dose>
                <rx:prescribed_dose_units cde="3065815" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.1">mg</rx:prescribed_dose_units>
                <rx:number_cycles cde="62590" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="1.8">4</rx:number_cycles>
                <rx:days_to_drug_therapy_start cde="" owner="TSS" precision="day" procurement_status="Completed" tier="1" xsd_ver="1.16">62</rx:days_to_drug_therapy_start>
                <rx:days_to_drug_therapy_end cde="" owner="TSS" precision="day" procurement_status="Completed" tier="1" xsd_ver="1.16">125</rx:days_to_drug_therapy_end>
                <rx:therapy_types>
                    <rx:therapy_type cde="2793530" owner="TSS" procurement_status="Completed" tier="" xsd_ver="2.1">Chemotherapy</rx:therapy_type>
                    <rx:therapy_type_notes cde="2001762" owner="TSS" procurement_status="Not Applicable" tier="" xsd_ver="2.1"/>
                </rx:therapy_types>
                <rx:drug_name cde="2975232" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="1.10">Cytoxan</rx:drug_name>
                <shared:regimen_indication cde="2793511" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="1.12">ADJUVANT</shared:regimen_indication>
                <shared:regimen_indication_notes cde="2793516" owner="TSS" procurement_status="Not Available" tier="2" xsd_ver="1.12"/>
                <rx:route_of_administrations>
                    <rx:route_of_administration cde="2003586" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.3">Intravenous (IV)</rx:route_of_administration>
                </rx:route_of_administrations>
                <rx:therapy_ongoing cde="3103479" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.2">NO</rx:therapy_ongoing>
                <shared:days_to_form_completion cde="" owner="TSS" precision="day" procurement_status="Completed" tier="" xsd_ver="1.16">868</shared:days_to_form_completion>
            </rx:drug>
            <rx:drug>
                <rx:regimen_number cde="2673845" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.1">2</rx:regimen_number>
                <rx:bcr_drug_barcode owner="TSS" procurement_status="Completed" xsd_ver="1.15">TCGA-A2-A0D0-D1852</rx:bcr_drug_barcode>
                <rx:bcr_drug_uuid cde="" owner="TSS" procurement_status="Completed" xsd_ver="2.3"/>
                <rx:drug_category cde="729" owner="TSS" procurement_status="Not Applicable" tier="2" xsd_ver="1.8"/>
                <rx:total_dose cde="1515" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.1">612</rx:total_dose>
                <rx:total_dose_units cde="3088785" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.1">mg</rx:total_dose_units>
                <rx:prescribed_dose cde="2184728" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.1">153</rx:prescribed_dose>
                <rx:prescribed_dose_units cde="3065815" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.1">mg</rx:prescribed_dose_units>
                <rx:number_cycles cde="62590" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="1.8">4</rx:number_cycles>
                <rx:days_to_drug_therapy_start cde="" owner="TSS" precision="day" procurement_status="Completed" tier="1" xsd_ver="1.16">62</rx:days_to_drug_therapy_start>
                <rx:days_to_drug_therapy_end cde="" owner="TSS" precision="day" procurement_status="Completed" tier="1" xsd_ver="1.16">125</rx:days_to_drug_therapy_end>
                <rx:therapy_types>
                    <rx:therapy_type cde="2793530" owner="TSS" procurement_status="Completed" tier="" xsd_ver="2.1">Chemotherapy</rx:therapy_type>
                    <rx:therapy_type_notes cde="2001762" owner="TSS" procurement_status="Not Applicable" tier="" xsd_ver="2.1"/>
                </rx:therapy_types>
                <rx:drug_name cde="2975232" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="1.10">Docetaxel</rx:drug_name>
                <shared:regimen_indication cde="2793511" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="1.12">ADJUVANT</shared:regimen_indication>
                <shared:regimen_indication_notes cde="2793516" owner="TSS" procurement_status="Not Available" tier="2" xsd_ver="1.12"/>
                <rx:route_of_administrations>
                    <rx:route_of_administration cde="2003586" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.3">Intravenous (IV)</rx:route_of_administration>
                </rx:route_of_administrations>
                <rx:therapy_ongoing cde="3103479" owner="TSS" procurement_status="Completed" tier="2" xsd_ver="2.2">NO</rx:therapy_ongoing>
                <shared:days_to_form_completion cde="" owner="TSS" precision="day" procurement_status="Completed" tier="" xsd_ver="1.16">868</shared:days_to_form_completion>
            </rx:drug>
        </rx:drugs>
        <rad:radiations/>
    </brca:patient>
</brca:tcga_bcr>